Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 15965573)

1.

A review of carvedilol arrhythmia data in clinical trials.

Kowey PR.

J Cardiovasc Pharmacol Ther. 2005 Jun;10 Suppl 1:S59-68. Review.

PMID:
15965573
2.

Role of carvedilol in atrial fibrillation: insights from clinical trials.

Gheorghiade M, Lukas MA.

Am J Cardiol. 2004 May 6;93(9A):53B-7B. Review.

PMID:
15144939
3.

Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era.

Reiffel JA.

J Cardiovasc Pharmacol Ther. 2005 Jun;10 Suppl 1:S45-58. Review.

PMID:
15965572
4.

Beta-blockers in heart failure. The 'new wave' of clinical trials.

Krum H.

Drugs. 1999 Aug;58(2):203-10. Review.

PMID:
10473016
5.
6.

Beta-blockers and amiodarone for the primary prevention of sudden cardiac death.

Frankenberger O, Steinberg JS.

Curr Cardiol Rep. 1999 Nov;1(4):274-81. Review.

PMID:
10980854
7.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

8.

Antiadrenergic therapy in the control of atrial fibrillation.

Naccarelli GV.

J Cardiovasc Pharmacol Ther. 2005 Jun;10 Suppl 1:S33-43. Review.

PMID:
15965571
10.

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.

Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A; COMET Investigators.

Am Heart J. 2005 Feb;149(2):370-6.

PMID:
15846279
12.

Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.

Bauman JL, Talbert RL.

J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):117-28. Review.

PMID:
15309248
13.

Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.

Hohnloser SH, Dorian P, Roberts R, Gent M, Israel CW, Fain E, Champagne J, Connolly SJ.

Circulation. 2006 Jul 11;114(2):104-9. Epub 2006 Jul 3.

14.

Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.

Ellison KE, Gandhi G.

Drugs. 2005;65(6):787-97. Review.

PMID:
15819591
15.

[Beta blockers in post-infarction state].

Schultheiss HP, Tschöpe C.

Herz. 2002 Aug;27 Suppl 1:26-9. German.

PMID:
12229255
16.

[Clinical trials on heart failure].

Cosín Aguilar J, Hernándiz Martínez A.

Rev Esp Cardiol. 2001;54 Suppl 1:22-31. Review. Spanish.

17.

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P.

Eur Heart J. 2005 Jul;26(13):1303-8. Epub 2005 Mar 14.

18.

Combination therapy with carvedilol and amiodarone in patients with severe heart failure.

Nägele H, Bohlmann M, Eck U, Petersen B, Rödiger W.

Eur J Heart Fail. 2000 Mar;2(1):71-9.

PMID:
10742706
19.

Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.

Maack C, Elter T, Böhm M.

Congest Heart Fail. 2003 Sep-Oct;9(5):263-70. Review.

PMID:
14564145
20.

New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.

Sackner-Bernstein JD.

Rev Cardiovasc Med. 2003;4 Suppl 3:S25-9. Review.

PMID:
14564231
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk